Sep 06, 2023 / 01:30PM GMT
Mohit Bansal - Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
Thank you very much for joining us today. My name is Mohit Bansal. I'm one of the biopharma analysts here at Wells Fargo. And I have Peter Griffith, the CFO of the company; and Arvind Sood, the greatest of all times. So thank you both for joining us today.
I'll turn it over to Peter for opening remarks here.
Peter H. Griffith - Amgen Inc. - Executive VP & CFO
Mohit, thank you very much. And actually, this is Murdo Gordon (inaudible). But good morning, and we're so glad to be here. Thanks for inviting us. As we always do at Amgen, let's start with patients and our mission to serve patients through discovering, developing, manufacturing and distributing first-in-class and best-in-class medicines to patients with grievous and serious illness all over the world.
We're creating value for patients, staff and shareholders, and are well positioned on any number of fronts that deliver long-term growth. We're driving a successful integration beginning off an early
Amgen Inc at Wells Fargo Healthcare Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers